These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15961791)

  • 21. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of plasma apolipoprotein F in Japanese healthy and hypertriglyceridemic subjects.
    Kujiraoka T; Nakamoto T; Sugimura H; Iwasaki T; Ishihara M; Hoshi T; Horie Y; Ogawa K; Todoroki M; Nakatani Y; Banba N; Yasu T; Hattori H
    J Atheroscler Thromb; 2013; 20(4):380-90. PubMed ID: 23370704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.
    Soedamah-Muthu SS; Colhoun HM; Taskinen MR; Idzior-Walus B; Fuller JH;
    Diabetologia; 2000 Nov; 43(11):1353-9. PubMed ID: 11126402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
    Spangenberg J; Curtiss LK
    Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzyme-linked immunosorbent assay (ELISA).
    Koritnik DL; Rudel LL
    J Lipid Res; 1983 Dec; 24(12):1639-45. PubMed ID: 6421975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
    Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
    Cohn JS; Batal R; Tremblay M; Jacques H; Veilleux L; Rodriguez C; Mamer O; Davignon J
    J Lipid Res; 2003 Oct; 44(10):1976-83. PubMed ID: 12867543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.
    Frikke-Schmidt R; Nordestgaard BG; Agerholm-Larsen B; Schnohr P; Tybjaerg-Hansen A
    J Lipid Res; 2000 Nov; 41(11):1812-22. PubMed ID: 11060351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
    Zhai G; Wen P; Guo L; Chen L
    Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes.
    Valabhji J; Donovan J; McColl AJ; Schachter M; Richmond W; Elkeles RS
    Diabet Med; 2002 May; 19(5):424-8. PubMed ID: 12027932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC; Watts GF; Nguyen MN; Barrett PH
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.
    Hogle DM; Smith RS; Curtiss LK
    J Lipid Res; 1988 Sep; 29(9):1221-9. PubMed ID: 3141545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms.
    Jia L; Bai H; Fu M; Xu Y; Yang Y; Long S
    Clin Chim Acta; 2005 Oct; 360(1-2):37-45. PubMed ID: 15925353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW; Ragland JB; Sabesin SM
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
    Sharma V; Witkowski A; Witkowska HE; Dykstra A; Simonsen JB; Nelbach L; Beckstead JA; Pullinger CR; Kane JP; Malloy MJ; Watson G; Forte TM; Ryan RO
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2254-60. PubMed ID: 25127531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.